Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: Should the INR targets be higher?
We present the case of a 34-year-old woman with a history of antiphospholipid syndrome with triple positivity for antiphospholipid antibodies, who had multiple thrombotic events, predominantly pulmonary embolic events, despite treatment with enoxaparin. She is currently on warfarin, with which she h...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2015
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23590
- Acceso en línea:
- https://doi.org/10.1136/bcr-2014-209013
https://repository.urosario.edu.co/handle/10336/23590
- Palabra clave:
- Enoxaparin
Lupus anticoagulant
Phospholipid antibody
Prothrombin complex
Rivaroxaban
Warfarin
Anticoagulant agent
Enoxaparin
Lupus anticoagulant
Warfarin
Adult
Anemia
Antiphospholipid syndrome
Article
Bleeding
Case report
Deep vein thrombosis
Drug treatment failure
Endarterectomy
Erythrocyte transfusion
Female
Food drug interaction
Hematuria
Human
International normalized ratio
Laboratory test
Lung embolism
Oxygen therapy
Patient compliance
Priority journal
Pulmonary hypertension
Thrombosis
Treatment duration
Upper gastrointestinal bleeding
Antiphospholipid syndrome
Blood
Chemically induced
Complication
Hematuria
Hemorrhage
International normalized ratio
Pulmonary embolism
Standards
Thrombosis
Treatment outcome
Adult
Anticoagulants
Antiphospholipid syndrome
Enoxaparin
Female
Hematuria
Hemorrhage
Humans
International normalized ratio
Lupus coagulation inhibitor
Pulmonary embolism
Thrombosis
Treatment outcome
Warfarin
- Rights
- License
- Abierto (Texto Completo)